Foot-and-mouth disease virus 3C protease mutant L127P: Implications for FMD vaccine development.

5 years ago

Foot-and-mouth disease virus 3C protease mutant L127P: Implications for FMD vaccine development.

Barrera J, Martel E, Turecek T, Neilan JG, Clark BA, Rasmussen M, Puckette M, Hurtle W, Pacheco JM, Gabbert L, Smith JD, Pisano M

The foot-and-mouth disease virus (FMDV) afflicts livestock in more than 80 countries limiting food production and global trade. Production of foot-and-mouth disease (FMD) vaccines requires cytosolic expression of the FMDV 3C protease to cleave the P1 polyprotein into mature capsid proteins, but the FMDV 3C protease is toxic to host cells. To identify less toxic isoforms of the FMDV 3C protease, we screened 3C mutants for increased transgene output over wild-type 3C using a Gaussia luciferase reporter system. The novel point-mutation 3C(L127P) increased yields of recombinant FMDV subunit proteins in mammalian and bacterial cells expressing P1-3C transgenes and retained the ability to process P1 polyproteins from multiple FMDV serotypes. The 3C(L127P) mutant produced crystalline-arrays of FMDV virus-like particles in mammalian and bacterial cells, potentially providing a practical method of rapid, inexpensive FMD vaccine production in bacteria.Importance: The mutant FMDV 3C protease L127P significantly increased yields of recombinant FMDV subunit antigens and produced virus-like particles in mammalian and bacterial cells. The L127P mutation provides a novel advancement for economical FMD vaccine production.

Publisher URL: https://www.ncbi.nlm.nih.gov/pubmed/28878081

DOI: PubMed:28878081